Dr. Meera Vimala Ragavan, MD
- Part D claims, 2024
- 47
- Publications
- 31
- Industry payments
- $2,060
- Affiliated sites
- 2
- Medical group
- 1
- Practice address
- 2238 Geary Blvd, San Francisco, CA 94115
- Practice phone
- Call (415) 833-3700
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
San Francisco Medical Center - Mammography
Mammography / Breast Imaging Center · San Francisco, California
Find Dr. Ragavan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Meera Vimala Ragavan is an internist in San Francisco, California
Dr. Ragavan practices at San Francisco Medical Center - Mammography in San Francisco, California.
Dr. Ragavan's NPI, 1053846410, was assigned on April 24, 2017. Dr. Ragavan graduated from Stanford University School Of Medicine in 2016. Dr. Ragavan holds California license A158519.
- NPI
- 1053846410NPI Registry (opens in a new tab)
- NPI enumeration date
- April 24, 2017
- NPI status
- Active
- Practice phone
- (415) 833-3700
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 35
- Medical school graduation
- 2016
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Meera Vimala Ragavan practices at San Francisco Medical Center - Mammography in San Francisco, California
Dr. Ragavan's primary practice is San Francisco Medical Center - Mammography, at 2238 Geary Blvd, San Francisco, CA 94115. The practice phone is (415) 833-3700.
- San Francisco Medical Center - Mammography2238 Geary Blvd, San Francisco, CA 94115Phone(415) 833-3700
Source: Dmand AI Affiliation Data
Dr. Meera Vimala Ragavan is affiliated with 2 sites of care and 1 medical group
Dr. Ragavan's primary practice is San Francisco Medical Center - Mammography in San Francisco, California. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Ragavan to 1 more group practice or clinic, named with a free account. Dr. Ragavan's employer is on file too: a breast imaging center.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Meera Vimala Ragavan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ragavan practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| San Francisco Medical Center - Mammography | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Meera Vimala Ragavan is one of 16,751 internists in California
Internal medicine is Dr. Ragavan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ragavan is board certified in internal medicine by the American Board of Internal Medicine. Dr. Ragavan is licensed in California.
Specialties and state licenses
- Internal medicine, CaliforniaPrimary
Internists near Dr. Ragavan
Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Meera Vimala Ragavan's patients have a median age of 58
Across all payers, Dmand AI patient panel data puts Dr. Ragavan's median patient age at 58, with 81% women.
Dr. Ragavan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 58
Patient panel by sex, all payers
- Women81%
- Men19%
Source: Dmand AI Patient Panel Data
Dr. Meera Vimala Ragavan wrote 47 Medicare Part D claims in 2024
In 2024, Dr. Ragavan wrote 47 Medicare Part D claims for 12 patients. 49% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $182,565 in total drug cost. In 2023, CMS named 12 claims across 1 drug.
Dr. Ragavan's Part D claims by kind of drug, 2024
- Generic23 claims49%
- Brand-name24 claims51%
Dr. Ragavan's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 122024: 118%
Drugs named by CMS: 1 in 2024, 1 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Meera Vimala Ragavan has 31 publications on record
Dmand AI links 31 papers to Dr. Ragavan, published from 2010 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Length of Stay. Dr. Ragavan has published most often in JCO Oncol Pract. Dr. Ragavan's most frequent co-authors are Manali Indravadan Patel, MD, MPH, Michael Douglas, MD and Hala Borno, MD.
Dr. Ragavan's papers by year, 2010 to 2025
Topics Dr. Ragavan writes about most
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Length of Stay
- Delivery of Health Care
- Health Expenditures
- Hospitals, Pediatric
- Prostatic Neoplasms
- Antineoplastic Agents
Dr. Ragavan's most frequent co-authors
- Manali Indravadan Patel, MD, MPH5 shared papers
- Michael Douglas, MD4 shared papers
- Hala Borno, MD3 shared papers
Recent publications by Dr. Ragavan
Support Care Cancer
See who Dr. Ragavan researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Ragavan works with, so you can find a warm path to the right internists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Meera Vimala Ragavan received $2,060 in industry payments in 2025
CMS Open Payments shows 2 general payments to Dr. Ragavan from 1 drug or device company in 2025. Consulting fees make up the largest share, 97% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,060.
General payments to Dr. Ragavan by kind, 2025 to 2025
- Consulting fees$2,00097%
- Food and beverage$603%
Companies that paid Dr. Ragavan the most, 2025 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Meera Vimala Ragavan graduated from Stanford University School Of Medicine
Dr. Ragavan graduated from Stanford University School Of Medicine in 2016.
- Medical school
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Meera Vimala Ragavan accepts plans from 2 insurance carriers
Dr. Ragavan is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
- Kaiser Permanente
- CMS Medicare
Plan types Dr. Ragavan accepts, by number of carriers
- EPO1
- HMO1
- Medicare1
- POS1
Source: Dmand AI Insurance Network Data
Sources for Dr. Meera Vimala Ragavan's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Meera Vimala Ragavan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Meera Vimala Ragavan's NPI number?
Dr. Meera Vimala Ragavan's NPI number is 1053846410. It was assigned on April 24, 2017, and it is active in the NPI Registry.
What kind of doctor is Dr. Meera Vimala Ragavan?
Dr. Meera Vimala Ragavan is an internist in San Francisco, California. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).
Where does Dr. Meera Vimala Ragavan practice?
Dr. Ragavan practices at 2238 Geary Blvd, San Francisco, CA 94115. Dr. Ragavan's primary practice is San Francisco Medical Center - Mammography in San Francisco, California. Dmand AI also links Dr. Ragavan to 1 group practice or clinic.
What is Dr. Meera Vimala Ragavan's office phone number?
The practice phone on file for Dr. Ragavan is (415) 833-3700.
What is Dr. Meera Vimala Ragavan's medical license number?
Dr. Ragavan holds California license A158519.
What medical group is Dr. Meera Vimala Ragavan part of?
Dr. Ragavan is linked to The Permanente Medical Group, Inc.
Is Dr. Meera Vimala Ragavan board certified?
Yes. Dr. Ragavan is board certified in internal medicine by the American Board of Internal Medicine.
Where did Dr. Meera Vimala Ragavan go to medical school?
Dr. Ragavan graduated from Stanford University School Of Medicine in 2016.
What drugs does Dr. Meera Vimala Ragavan prescribe most?
In 2024 Medicare Part D data, Dr. Ragavan's most prescribed drugs by claims were Tagrisso.
Has Dr. Meera Vimala Ragavan received payments from drug or device companies?
CMS Open Payments shows $2,060 in general payments to Dr. Ragavan from 1 company from 2025 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
Show 4 more questionsShow fewer questions
How long has Dr. Meera Vimala Ragavan been practicing?
Dr. Ragavan graduated from medical school in 2016, 10 years ago.
Does Dr. Meera Vimala Ragavan do research?
Dmand AI links 31 publications to Dr. Ragavan, published from 2010 to 2025.
Who does Dr. Meera Vimala Ragavan publish with?
Dr. Ragavan's most frequent co-authors are Manali Indravadan Patel, MD, MPH (5 shared papers), Michael Douglas, MD (4 shared papers) and Hala Borno, MD (3 shared papers).
What insurance does Dr. Meera Vimala Ragavan accept?
Dr. Ragavan is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
Selling to internal medicine practices?
See internists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card